J Balmer1, B V Stanzel2,3, M D Fischer4,5. 1. Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Great Britain. 2. Universitäts-Augenklinik Bonn, Universität Bonn, Bonn, Deutschland. 3. National Eye Institute, National Institutes of Health, Bethesda, USA. 4. Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Great Britain. dominik.fischer@med.uni-tuebingen.de. 5. Universitäts-Augenklinik, Department für Augenheilkunde, Universitätsklinikum Tübingen, Schleichstr. 12-16, 72076, Tübingen, Deutschland. dominik.fischer@med.uni-tuebingen.de.
Abstract
BACKGROUND: Due to an ageing population the incidence and prevalence of retinal diseases and visual disabilities will continue to grow. A great number of patients would principally be able to benefit from a stem cell-based therapy. OBJECTIVES: To introduce readers to the terminology and current concepts associated with stem cell therapy in ocular research and to provide an overview of the current status of preclinical and clinical research. MATERIAL AND METHODS: We performed a systematic review of relevant entries on ocular stem cell therapy for retinal diseases in PubMed and ClinicalTrials.gov. Differences between various stem cell types are displayed systematically, followed by a discussion of preclinical studies. Translational aspects are highlighted leading to the first clinical trials, including surgical and ethical facets. RESULTS: In preclinical studies, photoreceptor cell precursors and retinal pigment epithelium (RPE) cells were differentiated and subretinally transplanted into animal models. Besides exclusion of a teratoma formation, some functional improvements were also observed. Intraocular transplantation of stem cell-derived RPE cells was the first successful clinical application of pluripotent stem cells in man. CONCLUSION: Promising results of preclinical and clinical studies have identified important challenges and confirmed the potential of stem cell therapy for ophthalmology.
BACKGROUND: Due to an ageing population the incidence and prevalence of retinal diseases and visual disabilities will continue to grow. A great number of patients would principally be able to benefit from a stem cell-based therapy. OBJECTIVES: To introduce readers to the terminology and current concepts associated with stem cell therapy in ocular research and to provide an overview of the current status of preclinical and clinical research. MATERIAL AND METHODS: We performed a systematic review of relevant entries on ocular stem cell therapy for retinal diseases in PubMed and ClinicalTrials.gov. Differences between various stem cell types are displayed systematically, followed by a discussion of preclinical studies. Translational aspects are highlighted leading to the first clinical trials, including surgical and ethical facets. RESULTS: In preclinical studies, photoreceptor cell precursors and retinal pigment epithelium (RPE) cells were differentiated and subretinally transplanted into animal models. Besides exclusion of a teratoma formation, some functional improvements were also observed. Intraocular transplantation of stem cell-derived RPE cells was the first successful clinical application of pluripotent stem cells in man. CONCLUSION: Promising results of preclinical and clinical studies have identified important challenges and confirmed the potential of stem cell therapy for ophthalmology.
Authors: Amanda-Jayne F Carr; Matthew J K Smart; Conor M Ramsden; Michael B Powner; Lyndon da Cruz; Peter J Coffey Journal: Trends Neurosci Date: 2013-04-17 Impact factor: 13.837
Authors: Yong Liu; Ruilin Wang; Thomas I Zarembinski; Nate Doty; Caihui Jiang; Caio Regatieri; Xinmei Zhang; Michael J Young Journal: Tissue Eng Part A Date: 2012-10-12 Impact factor: 3.845
Authors: R E MacLaren; R A Pearson; A MacNeil; R H Douglas; T E Salt; M Akimoto; A Swaroop; J C Sowden; R R Ali Journal: Nature Date: 2006-11-09 Impact factor: 49.962
Authors: Budd A Tucker; Robert F Mullins; Luan M Streb; Kristin Anfinson; Mari E Eyestone; Emily Kaalberg; Megan J Riker; Arlene V Drack; Terry A Braun; Edwin M Stone Journal: Elife Date: 2013-08-27 Impact factor: 8.140
Authors: Anai Gonzalez-Cordero; Emma L West; Rachael A Pearson; Yanai Duran; Livia S Carvalho; Colin J Chu; Arifa Naeem; Samuel J I Blackford; Anastasios Georgiadis; Jorn Lakowski; Mike Hubank; Alexander J Smith; James W B Bainbridge; Jane C Sowden; Robin R Ali Journal: Nat Biotechnol Date: 2013-07-21 Impact factor: 54.908